Interactive Transcript
0:00
Okay, section two, viability imaging.
0:02
This is really one of the workhorses that caused cardiac MR
0:06
to really mature a lot over the last 20 years.
0:09
One of the first main applications of cardiac MR
0:12
that really had a clinical indication.
0:14
So it's really important to understand
0:17
what viability imaging is, uh, when we can use it, how
0:20
to do it well to perform cardiac mr.
0:23
So the goal of viability imaging is to identify
0:26
myocardial territories that are likely to recover
0:30
function following revascularization.
0:32
Usually that means after something like a coronary artery
0:36
bypass grafting.
0:37
In some instances it may be considering stunting the patient
0:40
or taking them to invasive
0:42
angiography for further evaluation.
0:44
But the goal is really to try to give the clinician an idea,
0:47
if I do a revascularization, it's gonna have an impact.
0:51
And here's just some examples
0:52
of late GA limb enhanced imaging.
0:55
Notice that these, again are short axis images.
0:59
The myocardium in this case is really dark black.
1:02
That's what we want. And then the hyper enhanced areas
1:06
of myocardium kind of seen in this region here on this image
1:11
and in this region here on this image,
1:13
that's late gadolinium enhancement.
1:15
And that's what it looks like when it's in
1:16
a vascular distribution.
1:17
So these are very classic images of LGE
1:21
that are used to assess viability.
1:24
So before we get too much further into the technique, uh,
1:28
I just want to provide a
1:30
background of the evidence for this.
1:31
Where does it even come from
1:32
that cardiac R can be used for this?
1:34
And uh, again, all the way back in the year 2000, Dr. Kim
1:39
and colleagues uh,
1:41
published a paper in the New England Journal
1:43
of Medicine showing that the extent of myocardial thickness
1:47
of LGE correlated with functional recovery in patients
1:51
that had infarct.
1:53
And you can see this bullet point list
1:56
that I have here is directly from the Society
1:58
of Cardiovascular Magnetic Resonance.
1:59
And I would highly recommend exploring that website
2:02
for further details on this if you're
2:04
interested in these topics.
2:06
But again, patients who had less hyper enhancement
2:10
of their myocardium had a higher likelihood
2:13
of functional improvement.
2:15
And they particularly found this threshold of 50%
2:18
of the myocardium.
2:20
And this can be very qualitative in, in many instances,
2:23
but about 50% of myocardial thickness, if you have more than
2:26
that showing hyper enhancement than your likelihood of
2:31
functional recovery of that segment is quite a bit lower.
2:34
And this is displayed again in this table
2:36
or in this graph in the top right this bar graph
2:38
where you can see after about 50% the height of the bars
2:42
represent the improved contractility with revascularization.
2:45
And you can see that in all these subgroups.
2:48
Once you kind of get to that, beyond that 50% threshold,
2:52
very low percent improved contractility
2:54
of each of these segments.
2:56
So this has kind of led to this idea that cardiac m mr
2:59
and percent kind of transmural
3:01
or extent of thickness of the myocardium is important
3:04
for understanding viability.
3:06
In another study by Gerber
3:07
and colleagues where they were looking at patients treated
3:10
with revascularization
3:11
or optimal medical therapy, actually the amount
3:14
of LGE seen on cardiac MR was an independent predictor
3:17
of mortality in patients with optimal medical therapy.
3:21
And the highest extent of LGE did actually the worst
3:24
of all groups in that study.
3:26
And one thing that's come up in maybe the last five years
3:30
as a result of something called the stitch trial is there's
3:32
a question of the actual value of viability where, uh,
3:36
stitch showed that doing revascularizations based off
3:39
of viability imaging did not have an impact
3:42
on functional recovery.
3:44
The issue with that is they only use spec
3:46
to determine viability.
3:47
There's been no prospectively randomized trials showing
3:51
what happens when you use cardiac MR
3:54
to do viability assessment
3:55
and revascularization based off of that.
3:57
So we're still a believer, uh, in viability imaging
4:00
and uh, most of our clinicians are as well, I would say,
4:03
and, and we still get plenty of referrals for this,
4:06
here's a basic viability imaging protocol.
4:09
So notice in the bottom in the kind of purple outline,
4:12
these are things that are optional sequences, things
4:14
that we do at my institution at least,
4:17
but aren't necessarily crucial
4:20
for actually doing viability imaging.
4:22
You can have a very, very brief protocol
4:25
and still do really good viability imaging.
4:27
So you can see that in this protocol. We start with scouts.
4:31
If we're just focusing on the kind
4:33
of non-optional sequences, then we do a set
4:35
of long axis syn images in the two, three,
4:38
and four chamber orientation.
4:39
Then you follow that up with short axi syn a acquisition
4:43
and then lake GA lay enhanced images.
4:45
And so really you should inject contrast.
4:47
Some people would inject contrast in this time point right
4:51
here after the short axis syn nase.
4:53
And then you have to wait 10 minutes
4:54
to do late gadolinium enhanced images.
4:56
We'll talk about why that's
4:57
important here in a couple minutes.
4:59
The way we do it is we actually inject contrast
5:02
before we do short axis syn nase
5:04
because then you're kind of got less dead time on the
5:06
scanner since you have to wait about 10 minutes to get
5:08
to LG imaging.
5:09
Anyways, so the first step as as I mentioned, CNA imaging,
5:14
uh, where we're looking for regional wall
5:15
motion abnormality is important.
5:17
And so kind of the things
5:18
to look at on CNA imaging is you should always assess
5:22
overall wall thickness.
5:23
This should be a done at end diastole.
5:26
And so if you're gonna call something thin,
5:28
it should be kind of relative to other normal segments
5:31
and how that looks at in diastole.
5:34
Okay, while motion abnormalities are actually based off
5:38
of the amount of thickening
5:40
that occurs in a myocardial segment,
5:42
not the overall squeeze,
5:43
sometimes it can be a little deceptive if somebody has a
5:47
poorly functioning segment or two
5:49
and the rest of the heart is moving okay,
5:51
and you're like, oh, the heart looks like it's beating
5:53
pretty well, the function's not that down,
5:56
but those segments themselves can be hypokinetic or worse
6:00
and can have a little deception.
6:01
So the terms that I'm using here,
6:03
and just for definition hypokinesis means reduced thickening
6:07
relative to other segments in the myocardium are relative
6:09
to sort of a normal amount of thickening.
6:11
A kinetic means there's no thickening,
6:13
so really no function occurring at all
6:15
within those segments.
6:17
And then dyskinetic is actually reversal
6:19
of the normal pattern of thickening.
6:21
So when the rest of the segments are kind
6:23
of contracting in this segment would be ballooning out,
6:26
a dyskinetic segment would be ballooning out.
6:28
And that's kind of, if you're calling something dyskinetic,
6:30
you're basically saying that there's an aneurysm
6:32
within the myocardium.
6:33
And so if we look here on the cynic lip to the right,
6:37
an example of this is we start to look kind
6:40
of here in the mid region of the myocardium here,
6:43
the anterior and anterior septal segments
6:46
are actually thinned out.
6:47
We watch that clip play through.
6:50
You can see in those few slices there in the middle row,
6:52
kind of anterior and interseptal segments are
6:55
relatively hypokinetic.
6:56
And we then we get some more thinning
6:58
and hypokinesis as we move more apically in that middle row
7:01
and bottom row as well, that starts
7:03
to become more circumferential.
7:05
And then probably the most important part
7:07
of this is understanding LGE imaging.
7:09
I'm gonna take a little quick detour of some physics here.
7:13
So this is really the only physics
7:15
that we'll have in the course today,
7:16
but I just think it's important to understand this.
7:18
So of course when we do LG imaging,
7:22
you know it's contrast enhanced imaging
7:23
and galene based contrast shortens T one.
7:26
So all of our imaging approaches for LGE are gonna be more
7:28
of AT one weighted approach to imaging.
7:31
And so just as a reminder, when we do T one weighted imaging
7:34
and all of MRI, we tip the kind
7:36
of main magnetic field there labeled
7:37
as MZ into the transverse plane.
7:40
And then we watch that recover along that Z axis over time.
7:44
And it's the degree of recovery
7:46
of the recovery time there along that Z axis
7:49
that determines T one.
7:51
And so this is just an example of
7:53
what T one recovery looks like in two different tissues.
7:56
You can see tissue A has a shorter T one tissue B has a
7:59
longer T one and T one is defined as 67%
8:02
of the total recovery along that MZ direction.
8:06
And so these two tissues would
8:07
have slightly different T ones.
8:09
And so in T one weighted imaging tissue A would be brighter
8:13
than tissue B, moving along to inversion recovery,
8:17
T one weighted inversion recovery imaging.
8:19
So now instead of just the standard spin echo technique,
8:21
which we see in the left
8:22
where we tip everything in the transverse plane,
8:25
which means we get to kind of MZ equals zero there
8:29
and then watch it recover
8:31
and inversion recover,
8:32
you actually tip everything 180 degrees.
8:34
So now it's kind of anti-parallel to the Z axis.
8:37
And then as it recovers there on the right
8:39
as we're recovering here, we actually now cross zero.
8:44
That's something that is gonna be very important in late
8:46
gado line and enhanced imaging here.
8:48
So inversion recovery, we tip down
8:51
and then we watch it recover and it recover as it recovers.
8:53
It crosses this axis where there's no magnetization.
8:57
And so that is exactly the principle
8:59
that we use in lake gadolinium enhancements.
9:01
So when we give contrast, we wait 10 minutes
9:05
and I'll tell you why that's important in just a second,
9:07
but we wait 10 minutes and then we perform our imaging.
9:09
But our goal again is to get normal myocardium,
9:12
really jet black here and then enhanced myocardium.
9:16
We want it to be bright. And so when we,
9:19
when we do our inversion recovery,
9:21
we tip everything down into the anti-parallel direction,
9:24
we watch it recover because infarcted tissue here in the
9:28
dark black line has taken up contrast.
9:31
It's T one is gonna be shorter than normal myocardium.
9:34
So as we watch these recover over time,
9:37
you should find a point where the normal myocardium crosses
9:41
that zero point and it's black and then enhanced myocardium
9:45
or myocardium that has gadolinium in it is gonna be bright.
9:49
And so we do something called a ti scout image
9:52
when we do LGE.
9:53
And it's exactly watching multiple frames over time of
9:57
of sort of AT one weighted inversion
9:58
and recovery image where you can say, okay, at that point
10:01
that's where the myocardium is black,
10:03
the normal myocardium is black.
10:04
And so that's where I wanna perform my LG imaging.
10:07
That gives you what's called an inversion time.
10:09
And you pick the inversion time then
10:11
and you actually run your full imaging
10:12
after you know what the inversion time is.
10:15
So why does this actually work?
10:17
Why does scar tissue take up gadolinium?
10:19
Well, if we look here at an arterial bed and,
10:23
and this can be a representative of a coronary arterial bed,
10:27
a normal look would be here on the left
10:30
where we have arterials,
10:31
they flow into arterial capillaries, venous capillaries,
10:33
then out through veins right in the middle
10:35
during an acute infarct, all the tissues
10:38
and things around this capillary bed are injured
10:42
or dying, you know, and there's inflammatory markers
10:45
and clot coming in.
10:46
And so this gets really damaged.
10:49
And so what happens then is in an acute injury,
10:54
you actually get, if you give contrast,
10:56
if you ga give gadolinium, it gets into the tissues,
11:00
it leaks out of these capillaries which are damaged
11:02
and then it can't get back out.
11:03
And so it sort of can show you where there's damage
11:07
because it can't, you know,
11:08
gadolinium gets in but it can't get back out.
11:11
So that's kind of an acute injury
11:13
and more chronic injury like we're talking about here in
11:17
viability imaging.
11:19
It actually, there is scar tissue that forms
11:21
and it's kind of the,
11:23
a similar concept except there's really no functioning
11:26
capillary or capillary beds in that scar tissue.
11:29
And so gadolinium again, will sort
11:31
of like seep in slowly into these areas of scar.
11:34
And then because there's really nothing
11:36
that can help it get out, it kind of gets trapped in there.
11:38
And over time people have figured out that about 10 minutes,
11:41
10 to 15 minutes
11:43
after you've give an injection, that's when you kind
11:45
of get optimal sort of leakage
11:47
and retention of gadolinium into these areas of scar.
11:50
And that's why we do LGE imaging
11:53
About 10 minutes after we inject contrast.
11:56
And here's just another example of how,
11:58
what this looks like, where you can see kind
12:00
of fibrotic myocardium here exemplified by sort
12:03
of all this fibrous tissue around
12:06
in the interstem of a myocardium here.
12:08
Once you give gadolinium that actually leaks in
12:11
through these capillary or or arterial beds
12:14
and then it sort of just gets retained in those areas
12:17
because it doesn't have a lot of vascularity to get it out.
12:21
Couple other notes here when you're thinking about LGE,
12:24
location absolutely matters.
12:26
So the chart on the left is a really good example of
12:30
a good way to think about LG imaging just in general,
12:33
whether you're thinking about ischemic heart disease
12:34
or non ischemic and really an ischemic heart disease,
12:39
you know, vascular related scarring.
12:41
What we want to see here is up in this upper left part
12:44
of the figure, part A here,
12:45
there's sub endocardial enhancement.
12:47
It's sub endocardial because that's part
12:50
of the myocardium that's most at risk.
12:52
It's the most distal part of vascular bed,
12:55
so it's most at risk.
12:56
And so scarring tends
12:57
to work its way from a sub endocardial space outward.
13:00
And so we can go all the way from very little enhancement
13:03
all the way to a transmural,
13:04
what's called a transmural infarct tear.
13:06
And then there's other forms of late gadolinium enhancement
13:10
for non-ischemic etiologies,
13:11
which I won't get into in this talk,
13:13
but can actually work quite well to sort
13:14
of distinguish various pathologies.
13:17
The other thing to note is kind
13:19
of coronary artery territories are important here.
13:21
So if we're gonna look for coronary artery disease
13:23
or coronary artery related injury to the myocardial,
13:26
we actually want the damage to follow a coronary territory.
13:30
And so it's important to know the,
13:31
this is the a ha 16 segment model where we,
13:34
if we go from base mid to apex,
13:36
certain segments here are supplied
13:38
by different vascular territories.
13:40
So you know, we have a reference one
13:41
of these up in our reading room.
13:43
Something that we're always thinking about when we're
13:45
thinking about vascular entry is,
13:47
does it follow a typical coronary artery distribution?
13:50
And here's just an example of mural extent.
13:53
So this is kind of in viability imaging, again,
13:55
the extent across the myocardium matters
13:58
and nice examples here, going from left to light, left
14:00
to right of, you know,
14:02
very little mural extent there in the septal region
14:06
and kind of working its way around
14:08
to something like about 26 to 50%.
14:11
So sort of still a viable tissue there in column two.
14:14
And then as we start getting more and more
14:16
and more, 51 to 75%
14:19
and then 76 to a hundred percent, these are
14:21
where you would start to describe things
14:23
as low likelihood of viability.
14:26
So last couple of points here.
14:28
What do we actually describe in viability imaging?
14:31
So the first thing is what regions
14:33
of the heart are involved functionally?
14:34
So is there wall thinning
14:36
and are there regional wall motion abnormalities by segment?
14:39
This is the same syn a I showed you
14:40
before where we saw some
14:42
of those regional wall motion abnormalities starting kind
14:44
of in the mid short axis views here involving the anterior
14:48
interseptal segments
14:49
and then getting more circumferential all the
14:51
way down towards the apex.
14:53
And then we wanna describe the segmental distribution of LGE
14:57
and then also give an indication of percent wall thickness.
15:00
So this is the same patient
15:01
and you can see highlighted by the arrows here,
15:04
starting really towards the base
15:05
and extending into the mid kind
15:07
of anterior septal anter, inferral septal.
15:10
And then working its way almost down to the kind of inferior
15:14
and septal segments of the apex.
15:16
We have lake ala enhancement.
15:19
And on this one it looks like if you compare it to sort
15:22
of normal parts of the LGE,
15:23
I would definitely say this is less than 50%
15:25
of the myocardium qualitatively.
15:27
And so this would be one where you would say,
15:29
this is probably high likelihood of functional recovery.
15:32
The only caveat to that,
15:34
and you can see on this two chamber short axis,
15:36
really the distal apex.
15:38
So probably the most distal part of what's being supplied
15:41
by LAD here in the inferior segment seems
15:43
to be almost transmural.
15:45
And you can nicely see that on that two chamber.
15:47
So that would be the one caveat in this case
15:49
where you'd say this is possibly a, a non-viable segment.